HARBIN, China, Sept. 8 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (''China Sky One Medical'' or ''the Company'') (Amex: CSY), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China (''PRC''), announced today that it will present at the upcoming second annual SIG Beijing Management Summit held September 10-12, 2008 at the Grand Hyatt Beijing Hotel in Beijing.

The second annual SIG Beijing Management Summit is a two-and-a-half-day conference that brings together executives from public and private companies based in China and other emerging Asian economies. The event will showcase leading companies in the Chinese consumer, healthcare, Internet, and technology sectors, as well as companies in the business services sector. Details of China Sky One's presentation follow:

    Date:    Friday, September 12, 2008
    Time:    10:20 a.m. Beijing time
    Venue:   The Grand Hyatt Beijing
             1 East Chang An Avenue
             Beijing, 100738

During the conference, the Company will be available to meet with analysts and portfolio managers. Participation in the second annual SIG Beijing Management Summit is by invitation only. Further information can be found at http://www.sig.com/ .

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company (''TDR'') and Harbin First Bio- Engineering Company Limited ('First'), the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as 'believe,' 'expect,' 'may,' 'will,' 'should,' 'project,' 'plan,' 'seek,' 'intend,' or 'anticipate' or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding our future plans, objectives or performance. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:
    Company Contact:
     China Sky One Medical, Inc.
     Mr. Yu-bo Hao, Board Secretary
     Tel:   +86-0451-53994069
     Email: china_sky_one@yahoo.cn
    CCG Investor Relations
     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915
     Email: crocker.coulson@ccgir.com
     Mr. Richard Micchelli, Financial Writer
     Tel:   +1-646-454-4516
     Email: richard.micchelli@ccgir.com
     Web:   http://www.ccgir.com

SOURCE China Sky One Medical, Inc.